ACR: Sulfasalazine reduces TNFi antibodies but more poorly than methotrexate
09/01/2016 - 15:02
SAN FRANCISCO – Sulfasalazine prevents formation of antibodies against tumor necrosis factor inhibitors, but probably not as well as methotrexate, a... More »